Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909)

Neurochemistry International

Volumn 53, Issue 6-8, 2008, Pages 370-373

  Stepanov, Vladimir ^a   Järv, Jaak ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Dopamine transporter; GBR12909; Isomerisation; Ligand binding kinetics; Ligand binding mechanism; PE2I; Transporter inhibitor

Indexed keywords

DOPAMINE TRANSPORTER; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; ISOMERIZATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RAT;

ANIMALS; BINDING, COMPETITIVE; BRAIN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; ISOMERISM; KINETICS; MOLECULAR STRUCTURE; PIPERAZINES; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS; TIME FACTORS;

RATTUS;

EID: 56349146439     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.09.005     Document Type: Article

References (15)

1. Bonnet J., Protais P., Chagraoui A., and Costentin J. High affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Eur. J. Pharmacol. 126 (1986) 211-222
2. i) and concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic-reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
3. Do-Rego J.-C., Hue H., Costentin J., and Bonnet J.-J. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine. J. Neurochem. 72 (1999) 396-404
4. Emond P., Garreau L., Chalon S., Boazi M., Caillet M., Bricard J., Frangin Y., Mauclaire L., Besnard J.C., and Guilloteau D. Synthesis and ligand binding of nortropane derivatives: N-substituted-2β-carbomethoxy-3β-(4′-iodophenyl) nortropane and N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3′,4′-disubstitutedphenyl) nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 40 9 (1997) 1366-1372
5. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C.G., Pauli S., and Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 120 Pt 3 (1997) 503-514
6. Herman B., Elkashef A., and Vocci F. Medications for the treatment of cocaine addiction: emerging candidates. Drug Discov. Today: Ther. Strateg. 2 (2005) 87-92
7. Hsin L., Chang L., Rothman R., Dersch C., Jacobson A., and Rice K. Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl) methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters. J. Med. Chem. 51 (2008) 2795-2806
8. Järv J., and Oras A. Similar dynamics of G-protein coupled receptors molecules in response to antagonist binding. Neurosci. Lett. 373 2 (2005) 150-152
9. Järv J., Hedlund B., and Bartfai T. Isomerization of the muscarinic receptor-antagonist complex. J. Biol. Chem. 254 13 (1979) 5595-5598
10. Laakso A., Bergman J., Haaparanta M., Vilkman H., Solin O., Syvalahti E., and Hietala J. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr. Res. 52 1/2 (2001) 115-120
11. 3H]GBR 12935 binding characteristics. Brain Res. 540 (1991) 1-13
12. Stepanov V., and Järv J. Slow isomerization step in the interaction between mouse dopamine transporter and dopamine reuptake inhibitor N-(3-iodoprop-2E-enyl)-2β-carbo-[3H]methoxy-3β-(4′-methylphenyl)nortropane. Neurosci. Lett. 410 3 (2006) 218-221
13. Stepanov V., Schou M., Järv J., and Halldin C. Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(4-methylphenyl) nortropane (PE2I) and its interaction with mice striatal membrane fragments. Appl. Radiat. Isot. 65 3 (2007) 293-300
14. Strickland S., Palmer G., and Massey V. Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data. J. Biol. Chem. 250 11 (1975) 4048-4052
15. van der Zee P., Koger H., Gootjes J., and Hespe W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15 (1980) 363-370